文献速递慢性静脉疾病静脉血栓栓塞

SailValve自膨胀深静脉瓣膜猪模型概念验证评估

Proof-of-Concept Evaluation of the SailValve Self-Expanding Deep Venous Valve System in a Porcine Model.
PubMed 文献 · J Endovasc Ther · 2017-03-30

在5头猪的10条髂静脉植入SailValve自膨胀深静脉瓣膜系统,评估其定位可行性、通畅性及瓣膜功能。结果显示全部技术性植入成功、随访期全部通畅,8个随访瓣膜中5个功能完整,1个见少量反流,2个因位置不当功能不足,组织学未见肉眼血栓但可见渐进性炎症反应。

要点

  • 猪髂静脉植入SailValve技术上可行,10条静脉全部即刻通畅且无围术期并发症。
  • 随访2或4周全部瓣膜保持通畅,8个瓣膜中5个功能完整,2个因位置不当功能不足。
  • 组织学未见肉眼血栓,但随访组可见对瓣膜的渐进性炎症反应。

核心结论

  • SailValve概念在猪模型中显示潜力:定位充分时瓣膜功能足够,短期随访无血栓性闭塞。
  • 未来需优化瓣膜材料并评估长期通畅性。

研究设计与样本

  • 研究纳入5头猪,双侧髂静脉共植入10枚SailValve装置。
  • 首只动物为急性先导实验,经股动脉入路验证精准定位可行性。
  • 其余4只动物按慢性植入方案随访2周(n=2)或4周(n=2)。
  • 所有动物在装置放置后及慢性植入动物处死时行顺行和逆行静脉造影评估通畅性与瓣膜功能。
  • 出于临床相关性考虑给予氯吡格雷和卡巴匹林钙方案,并由独立病理学家按预设方案行组织学分析。

主要发现

  • 10条髂静脉全部技术性植入成功,放置后即刻全部通畅。
  • 无围术期或术后并发症发生。
  • 随访动物顺行静脉造影证实所有瓣膜在2周或4周后保持通畅。
  • 逆行静脉造影显示8个瓣膜中5个功能完整,1个(4周组)见少量反流,其余2个(2周组)因位置不当功能不足。
  • 组织学未见肉眼血栓,随访组组织学显示对瓣膜的渐进性炎症反应。

临床怎么用

  • 动物实验提示SailValve定位准确时瓣膜功能充分且短期无血栓性闭塞,支持后续临床转化研究。
  • 定位不当可导致瓣膜功能不足,提示植入精准性是该系统发挥功能的关键。

局限性

  • 仅为猪模型小样本短期随访研究,最长随访4周。
  • 部分瓣膜因位置不当功能不足,且组织学可见渐进性炎症反应,材料与长期通畅性尚待优化验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the SailValve, a new self-expanding deep venous valve concept based on a single polytetrafluoroethylene cusp floating up and down in the bloodstream like a sail, acting as a flow regulator and allowing minimal reflux to reduce thrombogenicity. METHODS: Both iliac veins of 5 pigs were implanted with SailValve devices; the first animal was an acute pilot experiment to show the feasibility of accurately positioning the SailValve via a femoral access. The other 4 animals were followed for 2 weeks (n=2) or 4 weeks (n=2) under a chronic implantation protocol. Patency and valve function were evaluated directly in all animals using ascending and descending phlebography after device placement and at termination in the chronic implant animals. For reasons of clinical relevance, a regimen of clopidogrel and calcium carbasalate was administered. Histological analysis was performed according to a predefined protocol by an independent pathologist. RESULTS: Deployment was technically feasible in all 10 iliac veins, and all were patent directly after placement. No perioperative or postoperative complications occurred. Ascending phlebograms in the follow-up animals confirmed the patency of all valves after 2 or 4 weeks. Descending phlebograms showed full function in 5 of 8 valves. Limited reflux was seen in 1 valve (4-week group), and the function in the remaining 2 valves (2-week group) was insufficient because of malpositioning. No macroscopic thrombosis was noted on histology. Histology in the follow-up groups revealed a progressive inflammatory reaction to the valves. CONCLUSION: This animal study shows the potential of the SailValve concept with sufficient valve function after adequate positioning and no (thrombogenic) occlusions after short-term follow-up. Future research is essential to optimize valve material and long-term patency.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Boersma D, Vink A, Moll FL, et al. Proof-of-Concept Evaluation of the SailValve Self-Expanding Deep Venous Valve System in a Porcine Model. J Endovasc Ther. 2017. PMID: 28355935. doi:10.1177/1526602817700120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。